No writing assistance was utilized in the production of this manuscript. There are two forms of colistin available in the market: colistin sulfate (tablets or syrup for oral use and powder for ...

The following is a summary of “Systematic review and meta-analysis of colistin heteroresistance in Klebsiella pneumoniae ...

Department of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, China; ...

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

This valuable study addresses the growing threat of multi-drug-resistant (MDR) pathogens by focusing on the enhanced efficacy of colistin when combined with artesunate and EDTA against ...

据中国细菌耐药监测网（CHINET） 2024数据显示，碳青霉烯类耐药革兰阴性菌（CRO）感染仍是临床实践中亟需解决的困境与挑战，目前我国治疗CRO药物可及性较差，故对绝大部分CRO均有疗效的多黏菌素类药物的临床应用价值重新得到重视。

Analysis of data from 537 US hospitals reveals that ceftolozane-tazobactam and ceftazidime-avibactam are the most frequently ...

Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...

We discovered NDM-1, which stands for New Delhi metallo-beta-lactamase, at the end of 2009, but nobody cared about it too ...

AbbVie announced that the US FDA has approved aztreonam and avibactam (Emblaveo), in combination with metronidazole, for ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be approved by the FDA for complicated intra-abdominal infections with limited ...